Economic valuation of amitriptyline, desipramine, nortriptyline, and sertraline in the management of patients with depression
β Scribed by Tracy L. Skaer; David A. Sclar; Linda M. Robison; Richard S. Galin; Randall F. Legg; Neil L. Nemic
- Book ID
- 115851627
- Publisher
- Elsevier Science
- Year
- 1995
- Tongue
- English
- Weight
- 578 KB
- Volume
- 56
- Category
- Article
- ISSN
- 0011-393X
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Five elderly depressed patients were treated with amitriptyline (AT) and nortriptyline (NT) in turn, in a crossover design. Steady-state plasma drug levels were compared with those calculated for eight healthy subjects of previous single-dose studies. Plasma clearances were on average about 2.5 time
We assessed the effect of 3-month treatment of sertraline (50 mg) or low-dose amitriptyline (25 mg) on depression and quality of life in 31 patients with Parkinson's disease in a prospective single-blind randomized study. Both drugs significantly reduced the Hamilton Depression Rating Scale (HDRS-17